JNJ Related Mergers and Acquisitions
-
J&J's (JNJ) Janssen Sells 82M Elan (ELN) ADS
-
J&J (JNJ) Updates on Growth Strategies, Looking at Options for OCD Business
-
J&J's (JNJ) Venture Capital Unit Takes 10.7% Stake in Genmab A/S
-
Canccord Genuity Morning Coffee on Johnson & Johnson (JNJ); Good for the Bones, ja!
-
Johnson & Johnson (JNJ) Clears Final Regulatory Hurdle in Synthes Acquisition; Sets Closing Date
-
FTC Requires J&J (JNJ) to Sell DVR System for Wrist Fractures to Biomet -Bloomberg
-
Canaccord Genuity Morning Coffee on Avon Products (NYSE: AVP): Even Concealer Can't Fix This Mess
-
Reuters Says EU Commission Cleared J&J's (JNJ) Buy of Synthes; Traders Selling
-
Symmetry Medical (SMA) Completes Acquisition of Codman & Shurtleff, Inc., Offers New FY12 Guidance
-
Merck (MRK) Closes Sale of 50% Stake in J&J-Merck Consumer Pharma JV; Gets $175M
-
Johnson & Johnson (JNJ) to Acquire Synthes in $19.3B Deal
-
J&J (JNJ) Considering $20B Bid for Switzerland's Synthes
-
J&J (JNJ) in Talks to Buy Switzerland's Synthes for $20B -WSJ
-
Eli Lilly's (LLY) Elanco Makes Bid for Janssen's Animal Health Business (JNJ)
-
Johnson & Johnson (JNJ) Proposal to Acquire Crucell (CRXL) Achieves Minimum Acceptance
-
Smith & Nephew (SNN) Says It Is Not In Takeover Talks
-
Smith & Nephew (SNN) Surges On Reports of Johnson & Johnson (JNJ) Takeover Bid
-
Smith & Nephew Rejects $10.9B Takeover Bid from Johnson & Johnson (JNJ) Before Christmas
-
Water Street Announces Acquisition of OraPharma from Johnson & Johnson (JNJ)
-
Johnson & Johnson (JNJ) Announces Recommended Cash Offer for Crucell (CRXL)
-
Crucell (CRXL), J&J (JNJ) Moving Higher as Progress Being Made on Intended Offer
-
Johnson & Johnson (JNJ) to Acquire Remaining Crucell (CRXL) in €1.75B Transaction
-
Crucell (CRXL) Surges As J&J Seeks $2.3 Billion Buyout
-
Crucell (CRXL) In Advanced Talks to Be Acquired by Johnson & Johnson for $2.3 Billion
-
J&J Acquires Micrus Endovascular (MEND) To Expand In Neuro Devices
-
Johnson & Johnson (JNJ) Announces $480M Acquisition of Micrus Endovascular (MEND)
-
J&J (JNJ) to acquire Micrus (MEND) for $23.40/share
-
Devicor Bids to Acquire Breast Care Business from Johnson & Johnson (JNJ) Subsidiary
-
J&J's (JNJ) Ethicon Agrees to Buy Acclarent for $785M in Cash
-
J&J (JNJ) and Crucell (CRXL) Announce Strategic Collaboration, J&J Acquires 18% Stake
-
Johnson & Johnson (JNJ) and Elan Corporation plc (ELN) Announce Closing of Transaction Related to Alzheimer's Immunotherapy Program and Equity Investment
-
Elan (ELN) Falls As J&J (JNJ) Seeks Lower Price
-
Johnson & Johnson (JNJ) Completes Acquisition of Cougar Biotechnology
-
Johnson & Johnson (JNJ) To Acquire Alzheimer's Assets From Elan (ELN), Invests $1B For 18.4% Stake
-
JNJ (NYSE: JNJ) to Buy 18.4% Stake In Elan (NYSE: ELN) for $1B
-
Johnson & Johnson (JNJ) To Acquire Cougar Biotechnology (CGRB) For $43/Share
-
Needham & Co Reiterates a 'Buy' on Given Imaging (GIVN); Could be Attractive Acquisition Target
-
Already Speculation Johnson & Johnson (JNJ) Could Make Counter-Bid for Schering-Plough (SGP) - CNBC
-
Johnson & Johnson (JNJ) Completes Tender Offer of Mentor Corp (MNT)
-
Johnson & Johnson (JNJ) Receives Clearance for Tender to Buy Mentor; Sees Deal Dilutive to '09 EPS by $0.03-$0.05
-
Top 15 For 2008 (No. 14): M&A Wreckage
-
Johnson & Johnson (JNJ) Completes Acquisition of Omrix Biopharmaceuticals
-
Johnson & Johnson (JNJ) Commences Tender Offer to Buy Mentor (MNT)
-
Mentor (MNT) Agrees To Be Acquired By Johnson & Johnson (JNJ) for $31/Share
-
JNJ (JNJ) buys Mentor Corp. (MNT) for $31 per share
-
Johnson & Johnson To Acquire Omrix Biopharmaceuticals (OMRI) For $25/Share
-
Johnson & Johnson (JNJ) Acquires HealthMedia
-
Johnson & Johnson (JNJ) Announces Acquisition of Amic; Will Incur $40M Charge
-
Johnson & Johnson (JNJ) Receives FTC Clearance to Acquire Conor Medsystems (CONR)
-
Johnson & Johnson (JNJ) Receives FTC and EU Clearance to Acquire Pfizer's (PFE) Consumer Healthcare
Back to JNJ Stock Lookup
